Back to chapter

3.17:

Drug Metabolism: Phase I Reactions

JoVE 핵심
Pharmacology
JoVE 비디오를 활용하시려면 도서관을 통한 기관 구독이 필요합니다.  전체 비디오를 보시려면 로그인하거나 무료 트라이얼을 시작하세요.
JoVE 핵심 Pharmacology
Drug Metabolism: Phase I Reactions

Languages

소셜에 공유하기

A phase I reaction introduces a functionally reactive polar group. If the metabolite formed is polar enough, it is readily excreted in the urine. If the metabolite is nonpolar,  it undergoes a subsequent phase II reaction to form a more readily excretable polar conjugate. Phase I reactions occur mainly in the liver and are mostly catalyzed by the cytochrome P450 system of hemoproteins located in the lipophilic endoplasmic reticulum of the cells. In hepatic drug oxidation,  the oxidized form of P450 first combines with the parent drug. The binary-drug complex formed is reduced by NADPH–P450 reductase. The reduced complex uses molecular oxygen and a second electron to form an "activated oxygen"-P450-substrate complex. The activated oxygen is then transferred to the drug to produce the oxidized drug metabolite. In short, in a phase I reaction a parent drug is oxidized to introduce a  hydroxyl group via the monooxygenase P450 cycle.

3.17:

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar, it must undergo an additional phase II reaction. This subsequent reaction converts the nonpolar metabolite into a polar conjugate, enhancing its excretability. During hepatic drug oxidation, the oxidized form of P450 initially binds with the parent drug, creating a binary-drug complex. This complex is then reduced by NADPH–P450 reductase. Following this reduction, the complex uses molecular oxygen and another electron to form an "activated oxygen"-P450-substrate complex. The activated oxygen is then transferred to the drug, creating the oxidized drug metabolite. In conclusion, the monooxygenase P450 cycle plays a crucial role in a phase I reaction, oxidizing a parent drug and introducing a hydroxyl group.